CYTOKINETICS INC — Director's Dealing 2016

Jul 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2016-07-01

Reporting Person: Kaye Edward M. MD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-01	Non-Qualified Stock Option (right to buy)	$9.66	A	5175.0	Acquired	2026-07-01	Common Stock (5175)	Direct

Footnotes

F1: This option shall vest and become exercisable as to 5,175 shares divided into equal monthly installments such that the option shall be 100% vested on January 1, 2017.

F2: This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of an annual retainer of $20,000.